To: thebeach who wrote (47 ) 9/12/1998 1:48:00 PM From: Tim Cruise Read Replies (1) | Respond to of 356
Whitey & Beach, This conference would be a good place to go and meet with potential IR firms, particularly given the newly acquired Boston connections of the Company Tough market, but as the song says, "Time is on our side, yes it is". Tim Biotech Analysts Meg Malloy and Eric Schmidt Keynote First Informed Investors Boston Biotech Stocks Forum Sept. 15 BOSTON - August 3, 1998 - An in-depth look at companies, stocks and industry sectors that will grow in importance in the 21st Century will be the focus at the First Informed Investors Boston Biotechnology Forum Tuesday, Sept. 15 at the Back Bay Hilton. The Forum runs from 8:30 a.m.-4 p.m. (To listen to the audio-streaming of this event, live or archived,ÿclick here.) "We are excited about bringing our popular Informed Investors Forum format to Boston, after New York probably America's most important financial center," said Tim Quast, vice president and chief operating officer of Informed Investors, Inc. of Sacramento, CA. "For five years, we have been leveling the playing field for individual investors, giving them access to executives of public companies and leading industry authorities just as institutional investors and analysts receive. Moreover, we have developed a particular expertise in biotechnology and technology, both important industries in Boston. The presentation schedule is as follows (EDT): ------------------------------------------------------------------------ 8:45 a.m. - Eric Schmidt, Biotech Analyst, SG Cowen Securities 9:40 a.m.- Ilex Oncology and XOMA Corp. 10:20 a.m. - Biogen and Ligand Pharmaceuticals 11:10 a.m.- Genzyme Tissue Repair and Integra LifeSciences LUNCH BREAK 1ÿp.m. - Genzyme Transgenics and Avant Immunotherapeutics (formerly T Cell Sciences) 1:40 p.m. -Repligen and Creative BioMolecules 2:25 p.m. -ÿBoston Life Sciences and BioSource International 3:10 p.m. - Meg Malloy, Sr. Biotech Analyst, Hambrecht & Quist ------------------------------------------------------------------------ In Boston, two prominent biotech analysts, Meg Malloy of Hambrecht & Quist and Eric Schmidt, Ph.D of Cowen & Co., will give current insight and perspective on the rapidly-growing and fast-changing biotech industry. The cost to attend is $40 prepaid, $55 at the door. Call Informed Investors at 800-992-4683 to register. Audio tapes will be available for investors unable to attend. The full set (seven cassettes) are $50 plus $4.95 S/H which includes all company presentations plus keynote speakers. Individual tapes are $18. Transcripts of the Malloy's and Schmidt's comments are $25. Access Informed Investors' website at informedinvestors.com for more information and updates. In addition to Malloy and Schmidt, executives from 12 biotechnology companies will give 20-25 minute presentations, followed by Q&A, which replicate the format common at industry investment banking conferences that are typically closed to individual investors. The presenting companies are: Biogen (Nasdaq:BGEN); Biosource International (Nasdaq:BIOI); Boston Life Sciences (Nasdaq:BLSI); Creative BioMolecules (Nasdaq:CBMI); Genzyme Tissue Repair (Nasdaq:GENZL); Genzyme Transgenics (Nasdaq:GZTC); Ilex Oncology (Nasdaq:ILXO); Integra LifeSciences (Nasdaq:IART); Ligand Pharmaceuticals (Nasdaq:LGND); Repligen (Nasdaq:RGEN); T Cell Sciences (Nasdaq:TCEL) and XOMA Corp. (Nasdaq:XOMA) The Boston Forum is one in a succession of biotech/medtech forums sponsored by Informed Investors. Audio tapes are available for all Forums.